CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $29.31 million. The enterprise value is $20.71 million.
Important Dates
The next estimated earnings date is Wednesday, November 26, 2025, before market open.
| Earnings Date | Nov 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CLGN has 12.72 million shares outstanding. The number of shares has increased by 0.87% in one year.
| Current Share Class | 12.72M |
| Shares Outstanding | 12.72M |
| Shares Change (YoY) | +0.87% |
| Shares Change (QoQ) | +3.37% |
| Owned by Insiders (%) | 30.53% |
| Owned by Institutions (%) | 14.55% |
| Float | 8.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.74 |
| PS Ratio | 11.01 |
| Forward PS | 1.65 |
| PB Ratio | 2.33 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.24.
| Current Ratio | 4.60 |
| Quick Ratio | 4.30 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.25% and return on invested capital (ROIC) is -42.07%.
| Return on Equity (ROE) | -78.25% |
| Return on Assets (ROA) | -37.90% |
| Return on Invested Capital (ROIC) | -42.07% |
| Return on Capital Employed (ROCE) | -90.79% |
| Revenue Per Employee | $42,140 |
| Profits Per Employee | -$228,123 |
| Employee Count | 57 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 1.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.19% in the last 52 weeks. The beta is 0.79, so CLGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -52.19% |
| 50-Day Moving Average | 2.60 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 41.17 |
| Average Volume (20 Days) | 253,705 |
Short Selling Information
| Short Interest | 36,343 |
| Short Previous Month | 41,626 |
| Short % of Shares Out | 0.41% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.22 |
Income Statement
In the last 12 months, CLGN had revenue of $2.40 million and -$13.00 million in losses. Loss per share was -$1.13.
| Revenue | 2.40M |
| Gross Profit | 1.48M |
| Operating Income | -13.34M |
| Pretax Income | -13.00M |
| Net Income | -13.00M |
| EBITDA | -12.37M |
| EBIT | -13.34M |
| Loss Per Share | -$1.13 |
Full Income StatementBalance Sheet
The company has $11.43 million in cash and $3.03 million in debt, giving a net cash position of $8.41 million or $0.66 per share.
| Cash & Cash Equivalents | 11.43M |
| Total Debt | 3.03M |
| Net Cash | 8.41M |
| Net Cash Per Share | $0.66 |
| Equity (Book Value) | 12.51M |
| Book Value Per Share | 0.98 |
| Working Capital | 9.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.52 million and capital expenditures -$211,000, giving a free cash flow of -$10.73 million.
| Operating Cash Flow | -10.52M |
| Capital Expenditures | -211,000 |
| Free Cash Flow | -10.73M |
| FCF Per Share | -$0.84 |
Full Cash Flow StatementMargins
| Gross Margin | 61.78% |
| Operating Margin | -555.45% |
| Pretax Margin | -541.34% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.87% |
| Shareholder Yield | -0.87% |
| Earnings Yield | -44.65% |
| FCF Yield | -36.85% |
Analyst Forecast
The average price target for CLGN is $11.50, which is 398.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.50 |
| Price Target Difference | 398.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 1:1.5.
| Last Split Date | Nov 21, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:1.5 |
Scores
CLGN has an Altman Z-Score of -6.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.1 |
| Piotroski F-Score | 3 |
